Maxim Group Downgrades Momenta Pharmaceuticals (MNTA) to Sell
Tweet Send to a Friend
Maxim Group downgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Hold to Sell with a price target of $6.00.Analyst Jason McCarthy commented:With ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
